Cytokinetics (CYTK) had the highest return between December 11, 2023 and December 28, 2023 by a mid-cap US stock, returning 143.7%.
| ASSET | DATE | % RETURN |
|---|---|---|
Cytokinetics (CYTK) | 12/11/2023 - 12/28/2023 | 143.68% |
Bitdeer Technologies Group Class A Ordinary Shares (BTDR) | 12/11/2023 - 12/28/2023 | 124.07% |
Terawulf (WULF) | 12/11/2023 - 12/28/2023 | 75.58% |
GeneDx (WGS) | 12/11/2023 - 12/28/2023 | 71.43% |
Cipher Mining (CIFR) | 12/11/2023 - 12/28/2023 | 68.77% |
Hut 8 Corp Common Stock (HUT) | 12/11/2023 - 12/28/2023 | 68.55% |
Liquidia Technologies (LQDA) | 12/11/2023 - 12/28/2023 | 66.94% |
Century Aluminum (CENX) | 12/11/2023 - 12/28/2023 | 62.64% |
Compania de Minas Buenaventura SAA ADR (BVN) | 12/11/2023 - 12/28/2023 | 62.35% |
Sezzle Inc Common Stock (SEZL) | 12/11/2023 - 12/28/2023 | 61.13% |
Sunrun (RUN) | 12/11/2023 - 12/28/2023 | 58.5% |
Xometry (XMTR) | 12/11/2023 - 12/28/2023 | 57.49% |
CommScope (COMM) | 12/11/2023 - 12/28/2023 | 53.68% |
Immunitybio (IBRX) | 12/11/2023 - 12/28/2023 | 51.45% |
IREN (IREN) | 12/11/2023 - 12/28/2023 | 51.42% |
Arcutis Biotherapeutics (ARQT) | 12/11/2023 - 12/28/2023 | 50.68% |
Triumph (TGI) | 12/11/2023 - 12/28/2023 | 49.6% |
ACADIA Pharmaceuticals (ACAD) | 12/11/2023 - 12/28/2023 | 48.25% |
Recursion Pharmaceuticals (RXRX) | 12/11/2023 - 12/28/2023 | 40.16% |
Alcoa (AA) | 12/11/2023 - 12/28/2023 | 39.6% |
Apogee Therapeutics, Inc Common Stock (APGE) | 12/11/2023 - 12/28/2023 | 38.98% |
CleanSpark (CLSK) | 12/11/2023 - 12/28/2023 | 38.88% |
CAVA (CAVA) | 12/11/2023 - 12/28/2023 | 38.86% |
Compass (COMP) | 12/11/2023 - 12/28/2023 | 38.85% |
Verona Pharma PLC ADR (VRNA) | 12/11/2023 - 12/28/2023 | 37.61% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
